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Reciprocal Interactions of Pit1 and GATA2
Mediate Signaling Gradient±Induced
Determination of Pituitary Cell Types
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tropes, secreting adrenocorticotropin hormone (ACTH);
melanotropes, secreting melanocyte-stimulating hormone
(MSH); thyrotropes, secreting thyroid-stimulating hormone
(TSH); gonadotropes, secreting luteinizing hormone (LH)
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The pituitary gland is initially derived from the most
anterior portion of the neural ridge and arises as an
invagination of oral ectoderm, referred to as Rathke'sSummary
pouch, that makes direct cell±cell contact with the over-
lying neural epithelium of the ventral diencephalon be-The mechanisms by which transient gradients of sig-
tween embryonic days 8.5±9.0 (e8.5±e9.0) in mousenaling molecules lead to emergence of specific cell
(Jacobson et al., 1979; Couly and Le Douarin, 1988;types remain a central question in mammalian organo-
Eagleson and Harris, 1990). It has been demonstratedgenesis. Here, we demonstrate that the appearance
that direct contact of the ventral diencephalon withof four ventral pituitary cell types is mediated via the
Rathke's pouch is required for pituitary organogenesisreciprocal interactions of two transcription factors,
and that pituitary cell type determination occurs in re-Pit1 and GATA2, which are epistatic to the remainder
sponse to a series of extrinsic and intrinsic signalingof the cell type±specific transcription programs and
molecules (Ericson et al., 1998; Takuma et al., 1998;serve as the molecular memory of the transient signal-
Treier et al., 1998). BMP4, Wnt5a, and FGF8 are ex-ing events. Unexpectedly, this program includes a DNA
pressed in distinct, overlapping patterns in the ventralbinding±independent function of Pit1, suppressing the
diencephalon, while Shh, uniformly expressed in the oralventral GATA2-dependent gonadotrope program by
ectoderm, is excluded from the region that forms Rathke'sinhibiting GATA2 binding to gonadotrope- but not thy-
pouch, creating a molecular boundary in the continuousrotrope-specific genes, indicating that both DNA bind-
ectoderm. Both in vivo (Treier et al., 1998) and organ
ing±dependent and ±independent actions of abundant
culture experiments (Ericson et al., 1998; Treier et al.,
determining factors contribute to generate distinct cell 1998) have demonstrated that BMP4 is required for the
phenotypes. initial phase of organ commitment, with subsequent op-
posing ventral→dorsal BMP2 and dorsal→ventral FGF8
Introduction gradients serving to determine ventral/intermediate cell
phenotypes (gonadotropes, thyrotropes, somatotropes,
The development of specific cell types during mamma- lactotropes) and dorsal cell phenotypes (melanotropes
lian organogenesis appears to involve molecular strate- and corticotropes), respectively, with attenuation of the
gies analogous to those utilized for initial patterning in BMP2 signal ultimately required for terminal differenti-
Drosophila development, involving gradients of signal- ation.
ing molecules that generate overlapping patterns of tran- A consequence of these signaling gradients is appar-
scription factors (reviewed in Rusch and Levine, 1996). ently to establish overlapping expression patterns of
The pituitary gland provides an ideal model system for several transcription factors in Rathke's pouch, allowing
understanding the transcriptional programs that medi- positional determination of pituitary cell types by e10.5±
ate the signaling gradient±induced positional determi- e12.5. Several factors exhibit spatially restricted do-
nation events, as the cell phenotypes are well character- mains of expression, including Isl1 (Treier et al., 1998)
ized and the critical morphogen gradients required for and Brn4 (Sornson et al., 1996) at the ventral boundary
the emergence of cell types have been recently defined and Prop1 (Sornson et al., 1996) and Nkx3.1 (Bieberich et
al., 1996) dorsally between e10.5±e12.5. Subsequently,(Ericson et al., 1998; Takuma et al., 1998; Treier et al.,
prior to appearance of specific anterior pituitary cell1998).
types, the tissue-specific POU domain transcription fac-The mature pituitary gland contains six phenotypically
tor Pit1, required for initial activation of growth hormone,distinct cell types that arise from a common primordium
prolactin, and thyroid-stimulating hormone in definitivein a spatially and temporally specific fashion (Simmons
thyrotropes, is expressed in an intermediate caudome-et al., 1990; Japon et al., 1994) and serve critical homeo-
dial field (Simmons et al., 1990; Li et al., 1990), while thestatic functions by regulating key endocrine organ tar-
orphan nuclear receptor SF1 is selectively expressed ingets in response to signals from brain and periphery.
the most ventrally arising pituitary cell type, the gonado-
trope (Ingraham et al., 1994; Luo et al., 1994).§ To whom correspondence should be addressed (e-mail: mrosen
feld@ucsd.edu). Thus, a central goal in pituitary development has been
Cell
588
Figure 1. Ventral Induction of GATA2 in the
Pituitary by BMP
(A) Schematic representations of the different
stages of pituitary organogenesis. Pituitary
cell types are positionally determined in re-
sponse to signaling gradients between e10.5±
e12.5, with definitive cell commitment oc-
curring by e17.5. INF, infundibular compo-
nent of the ventral diencephalon; r, rostral; C,
corticotropes; S/L, somatotropes/lactotropes;
T, thyrotropes; G, gonadotropes; VD, ventral
diencephalon; HB, hindbrain; PL, posterior
lobe.
(B) In situ hybridization demonstrating ontog-
eny of GATA2 expression in the developing
pituitary beginning at e10.5 at the ventral
boundary of Rathke's pouch (RP) and re-
maining ventral throughout early embryonic
development, with highest expression appar-
ent in the most ventral region.
(C) Expression of ventrally expressed genes
at e10.5; the common hormone subunit of
thyrotropes and gonadotropes aGSU and the
transcription factors P-Frk, Isl1, and Brn4.
(D) Transient expression of GATA3 is de-
tected in the pituitary at e10.5 but is absent
by e13.5.
(E) Colocalization of GATA2 protein with the
aGSU-expressing pituitary cell lineages: TSHb
in thyrotropes (arrow) and FSHb in gonado-
tropes (arrowheads).
(F) Induction of GATA2 expression in animals overexpressing BMP2/4 but not Shh under control of aGSU regulatory sequences. GATA2
expression is detected by in situ hybridization of e17.5 transgenic founder animals. Reduced sensitivity in detection of expression levels of
GATA2 in the wild-type littermate from the aGSU-BMP4 transgene is due to the smaller section width in the analysis of these animals (5 mm
vs. 20 mm for all other sections in this figure).
to address the molecular mechanisms by which the tran- e11 (Figure 1C). Transcripts for GATA3 are also tran-
sient signaling gradients establish the transcriptional siently detected in the pituitary, showing ventral expres-
programs that dictate cell type specification. In this pa- sion similar to that of GATA2 at e10.5, but become
per, we demonstrate that two induced factors, Pit1 and undetectable by e13.5, prior to the appearance of the
GATA2, by reciprocal interactions and based on both initial markers of ventral cell determination (Figure 1D).
DNA binding±dependent and ±independent actions, Double-label immunohistochemistry colocalizes expres-
provide the molecular memory in vivo that mediates the sion of GATA2 protein in the adult pituitary to the two
effects of transient signaling gradients in determining most ventrally arising cell types, gonadotropes and Pit1-
pituitary cell types. dependent thyrotropes (Figure 1E).
Based on the ventral induction of a series of transcrip-
tion factors, including GATA2, we examined in vivo
Results
whether dorsally expanding the expression of the ventral
signaling molecules BMP2 or Shh under control of 15
BMP2 Induces Ventral Expression of GATA2
kb aGSU 59-flanking information, which targets expres-To investigate the hypothesis that morphogen-induced
sion to Rathke's pouch and later to thyrotropes andtranscription factors mediate the determination of pitu-
gonadotropes, would dorsally expand specific ventrallyitary cell types, we explored the transcription factor±
induced genes. BMP2, normally expressed at the ventralencoding genes initially expressed at the ventral bound-
boundary of Shh restriction out of the nascent Rathke'sary of the developing Rathke's pouch. In vivo data have
pouch, is required for the appearance of four pituitarysuggested that pituitary cell type positional determina-
cell types (Ericson et al., 1998; Treier et al., 1998). Wetion can occur between e10.5±e12.5, long before termi-
find that expression of BMP2/4 under control of aGSUnally differentiated cell types appear between e15.5±
results in a dramatic transcriptional induction as well ase16.5 (Figure 1A). We observed that the gene encoding
dorsal expansion of GATA2 gene expression (Figure 1F),the zinc finger protein GATA2 exhibits ventral induction
whereas other ventrally expressed genes are not directlyin the pituitary coincident with the closure of Rathke's
induced. In contrast, overexpression of Shh in vivo underpouch at e10.5 and is maintained with highest expres-
aGSU does not lead directly to transcriptional inductionsion levels ventrally throughout early pituitary develop-
of GATA2 (Figure 1F). These data are consistent withment (Figure 1B), later becoming expressed diffusely as
the hypothesis that expression of GATA2 in the pituitarythe adult pituitary cell populations lose spatial restric-
is selectively induced in response to the ventral BMP2tion. GATA2 therefore exhibits ventral inductive patterns
signal, with highest levels of GATA2 present in the mostsimilar to the genes encoding the transcription factors
Brn4, Isl1, and P-Frk as well as aGSU between e10.5± ventral cell type, the presumptive gonadotrope precursors.
Figure 2. Conversion of Pituitary Cell Types by Dorsal Expression of GATA2
(A) Loss of Pit1-dependent cell lineages and Pit1 expression in Pit1/GATA2 transgenic animals. In situ hybridization of e16.5 Pit1/GATA2
transgenic embryos demonstrated that expression of growth hormone (GH) and caudomedial thyroid-stimulating hormone (TSHb) are absent
with a severe inhibition of Pit1 expression, whereas aGSU and GATA2 expression expand dorsally. The Pit1-independent rostral tip thyrotrope
population is unaffected in Pit1/GATA2 animals.
(B) Expansion of the gonadotrope lineage in Pit1/GATA2 animals. Immunohistochemistry of P0 Pit1/GATA2 embryos revealed a loss of GH, TSHb,
and prolactin (Prl) protein and an expansion of gonadotrope cell types expressing glycoprotein subunit-a (aGSU) and luteinizing hormone (LHb).
(C) Epistatic relationship of GATA2 and other ventral markers. Expression of the genes for the ventral markers LHb, Isl1, and SF1 are dorsally
expanded in P0 animals. Expression of P-Frk is also dorsally expanded (data not shown).
(D) Immunohistochemistry of adult Pit1/GATA2 pituitaries reveals that gonadotrope cell types are derived from the transgene. The expression
of the transgene (HA, rhodamine-labeled nuclei) colocalizes with gonadotrope markers (aGSU and FSHb, fluorescein labeled). Nonlabeled
nuclei represent the endogenous gonadotrope lineage. Wild-type pituitaries analyzed in parallel contained 5%±10% aGSU-expressing cells
(data not shown). Identical results were obtained from two separate transgenic lines.
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Figure 3. Roles of GATA2 in Ventral Pituitary Cell Type Determination
(A) Analysis of animals expressing GATA2 under control of growth hormone regulatory sequences. Expression of GATA2 is detected by in
situ hybridization of e18.5 GH/GATA2 founder animals showing expression in the presumptive somatotrope region. No changes in Pit1, GH,
LHb, or TSHb are detected.
(B) Dominant inhibition of GATA2 activation by an engrailed GATA2 fusion. ªdnGATA2º refers to the dominant-negative GATA2 expression
construct, whereas ªdnCMXº contains the engrailed domain alone. These vectors are tested on promoters containing low-basal (P36; Lin et
al., 1994) and high-basal (TK) activities and are presented as fold activation or repression over the reporter alone.
(C) In vivo expression of a dominant-negative GATA2 inhibits terminal differentiation of gonadotropes and thyrotropes. Analysis of e18.5
aGSU/dnGATA2 animals reveals the absence of LHb expression and a severe decrease in TSHb and aGSU expression. The gonadotrope-
specific marker SF1 is absent, and GATA2 expression level is itself mildly reduced. Pit1 expression also expands ventrally and rostrally. Two
founders were analyzed for both transgenic constructs. Arrows indicate rostral shoulder region of anterior pituitary.
Dorsal Expression of GATA2 Converts Pituitary GATA2 animals, including the ventral lineage marker Isl1
and the gonadotrope marker SF1 (Figure 2C). Con-Cell Types to Gonadotropes
If GATA2 were to represent the critical factor that medi- versely, there is marked inhibition of Pit1 gene expres-
sion (Figures 2A and 2C). Double labeling with antibod-ates the signal gradient±induced ventral determination
program, then it should potentially be alone sufficient ies to define cells expressing the HA-tagged GATA2
transgene reveals that adult pituitaries contain predomi-to impose this program on the more dorsally located
Pit1 cell lineages. We therefore targeted expression of nantly gonadotrope cells (.90% of total cells) and that
all GATA2-expressing cells derived from the transgeneGATA2 in vivo using 15 kb of Pit1 59-regulatory informa-
tion (Rhodes et al., 1993) to test whether extending the (HA positive) also express aGSU (Figure 2D). There is
also a late appearance of some TSHb-positive cellsexpression of GATA2 more dorsally would be sufficient
to alter the fate of the Pit1-dependent cell types that (data not shown). These results demonstrate that GATA2
is alone sufficient to induce the gonadotrope fate in thewould normally generate somatotropes, lactotropes, and
thyrotropes. Analysis of pituitary glands from animals context of the more dorsally arising cell lineages and
suggest an epistatic relationship between GATA2 andexpressing the Pit1/GATA2 transgene reveals that initial
activation of growth hormone, prolactin, and Pit1-depen- the remainder of the gonadotrope transcriptional pro-
gram. In contrast, targeting of the ventrally induced ho-dent thyroid-stimulating hormone b fails to occur at
e16.5 (Figure 2A), remaining undetectable at P0 (Figure meodomain factor Isl1 under the identical promoter fails
to convert the Pit1 lineages to gonadotropes (data not2B) and in the adult. In contrast, whereas the terminal
differentiation marker for gonadotrope development, shown) or inhibit Pit1 expression, demonstrating that
the induction of the gonadotrope program is a specificLHb, is normally restricted to the most ventral portion
of the gland at P0 in wild-type animals, the pituitary effect of GATA2.
glands of Pit1/GATA2 mice exhibit a dramatically ex-
panded gonadotrope population, extending dorsally GATA2 Restriction of Pit1 Initial Activation
The conversion of the Pit1 lineage by GATA2 to a gonad-(Figures 2B and 2C).
In parallel, a series of markers normally confined to otrope fate, despite normal expression of GATA2 in both
gonadotropes and thyrotropes, is potentially explainedventral expression also exhibit dorsal expansion in Pit1/
DNA Binding±Independent Cell Specification by Pit1
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(GH) promoter, after Pit1 autoregulation commences,
results in transgenic embryos displaying high levels of
GATA2 expression in the presumptive somatotrope re-
gion but maintains normal expression of growth hor-
mone and Pit1 and no alterations from the normal ex-
pression of other cell type markers at e18.5 (Figure 3A).
Thus, expression of GATA2 following terminal differenti-
ation of a specific cell type (somatotropes) fails to alter
the normal transcriptional programs or affect Pit1 gene
expression once it is driven by the late, autoregulatory
gene enhancer.
Role of GATA2 in the Determination
of Ventral Pituitary Cell Types
These actions of GATA2 in pituitary cell type determina-
tion are consistent with the critical developmental roles
of members of the GATA family in hematopoietic, cardio-
vascular, and other organ systems (Pevny et al., 1991;
Tsai et al., 1994; Pandolfi et al., 1995; Kuo et al., 1997;
Molkentin et al., 1997). As mice homozygous for deletion
of the GATA2 genomic locus die prior to critical events
in pituitary organogenesis (Tsai et al., 1994), we wished
to further investigate the requirement of GATA2 as a
transcriptional activator in the determination of both go-
nadotropes and thyrotropes. We therefore generated
transgenic mice expressing a dominant-negative GATA2
(dnGATA2) by replacing the N-terminal transcriptional
activation domain of GATA2 with the repressor domain
of the Drosophila Engrailed protein (Jaynes and O'Far-
rell, 1991; Han and Manley, 1993). In transient transfec-
tion assays, the dnGATA2 is capable of dominant inhibi-
tion of wild-type GATA2 function as well as repression
of a GATA-TK reporter (Figure 3B). We targeted expres-
sion of the dnGATA2 in gonadotropes and thyrotropes
under the control of 15 kb aGSU regulatory sequences
and analyzed transgenic mice at e18.5. In these animals,
both GATA2-expressing cell types are affected, as nei-
Figure 4. Ventral Expression of Pit1 Converts Gonadotropes to ther gonadotrope-specific (LHb, SF1) or thyrotrope-spe-
Thyrotropes cific (TSHb) cell type markers are fully expressed, and
(A) In situ hybridization of e18.5 aGSU/Pit1 transgenic founder ani- aGSU expression is also diminished (Figure 3C). Consis-
mals showing expression of the Pit1 transgene in the most ventral tent with the model that GATA2 restricts Pit1 expression
pituitary cell types (rPit1). Expression of GH is grossly normal,
from presumptive gonadotropes, the field of Pit1 ex-whereas the expression of TSHb expands into the presumptive go-
pression in these pituitaries is now extended ventrallynadotrope region. Markers for gonadotrope determination (LHb and
and rostrally to include the gonadotrope field (FigureSF1) are lost. Ventral expression of Pit1 does not appear to affect
GATA2 levels. An occasional growth hormone±positive cell is also 3C). Within the limitations inherent to in vivo dominant-
occasionally observed in the rostral tip region of the pituitary. negative experiments, these data are consistent with the
(B) Effects of ventral Pit1 expression analyzed by immunohisto- hypothesis that GATA2 is required for both gonadotrope
chemistry. Loss of LHb-positive cells in the rostral/ventral region of
and thyrotrope cell type determination and further sup-the pituitary coincides with a reciprocal increase in the number of
port the hypothesis that the high levels of GATA2 in theTSHb-positive cells. Arrows indicate the expansion of the TSHb1
presumptive gonadotropes create the ventral exclusionpopulation in the rostral shoulder of the pituitary. Identical results
were obtained from three separate founder animals. boundary of the Pit1 field.
Pit1 Can Convert Gonadotropes to Thyrotropes
Based on the requirement for Pit1 function in thyrotropeby the marked inhibition of Pit1 gene expression in Pit1/
GATA2 animals (Figures 2A and 2B). Pit1 gene expres- development (Li et al., 1990) and its absence in the
gonadotrope, we next wished to test whether extendingsion is initially activated on e13.5 under control of a
specific early gene enhancer but subsequently requires the expression domain of Pit1 to include the field of
GATA21 cells from which the gonadotropes are deter-an autoregulated distal enhancer between e16.5±e17.5
(DiMattia et al., 1997). If GATA2 were to act by suppres- mined would ªswitchº their determination from a gonad-
otrope to a thyrotrope phenotype. Using 15 kb of aGSUsion of the Pit1 earlyÐbut not autoregulatoryÐenhancer,
then GATA2 might fail to induce a cell type switch once regulatory sequences to target ventral expression of
Pit1, we analyzed transgenic founder animals on e18.5,Pit1 autoregulation begins at the time of terminal differ-
entiation (e16.5±e17.5). Indeed, targeting GATA2 expres- expressing Pit1, as determined using an in situ probe
specific for the transgene (rPit1; Figure 4A). Pituitariession under control of 1.7 kb of the rat growth hormone
Figure 5. Physical and Functional Interaction between Pit1 and GATA2
(A) Immunoprecipitation of GATA2 from extracts of pituitary cells expressing Pit1 alone (lane 1) or Pit1 and GATA2 (lane 2) using aPit1 IgG,
analyzed using a specific antibody to recognize GATA2. The secondary antibody also recognizes the IgG heavy chain (IgG). No coprecipitation
is observed with nonspecific IgG (data not shown).
(B) Inhibition of GATA2 binding by Pit1. Electrophoresis gel mobility shift assays (EMSA) were performed using the indicated molar ratios of
Pit1 and GATA2 protein generated by in vitro transcription and translation (TnT). GATA2 binding is inhibited by Pit1 on both a consensus
ªCONSº site and a site from the SF1 promoter.
(C) Similarly, Pit1 is capable of inhibition of GATA2-dependent transactivation of a reporter (83GATA-RE P36) in transfection assays.
DNA Binding±Independent Cell Specification by Pit1
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from aGSU/Pit1 animals are characterized by the near 1993) to be the critical major groove DNA-binding resi-
dues in the zinc finger of GATA proteins appears to havecomplete absence of the gonadotrope-specific markers
LHb and SF1 and a reciprocal, pronounced increase in no effect or to only partially weaken interactions with
Pit1 (Figure 5G).the expression of both TSHb mRNA and protein (Figures
4A and 4B). The expansion of TSHb-positive cells is We find that this inhibition of GATA2 DNA binding by
Pit1 does not occur on the TSHb promoter, which har-particularly prominent at the rostral shoulder of the me-
dial part of the gland (Figure 4B), presumably the loca- bors both low-affinity Pit1 (Lin et al., 1994) and GATA2
DNA-binding sites (Figure 5H; Gordon et al., 1997). Bind-tion in which the gonadotrope lineage arises, as marked
by the expression pattern of SF1 during normal pituitary ing of GATA2 to the TSHb promoter is, however, inhib-
ited when the Pit1 sites have been deleted (Figure 5H).ontogeny. Extending the expression of Pit1 ventrally
does not affect expression of GATA2, indicating that the Similarly, in transient transfection assays, Pit1 and
GATA2 exert synergistic effects on the TSHb promoterloss of the gonadotrope cell type is not due to inhibitory
actions of Pit1 on GATA2 gene expression. Thus, within (Figure 5I), as has been previously reported (Gordon et
al., 1997). These observations suggest a model in whichthe context of the most ventral cell population, the pres-
ence or absence of Pit1 appears to be sufficient to deter- Pit1 can inhibit transactivation by GATA2 on GATA2-
dependent promoters that do not contain adjacent Pit1-mine differentiation to either a thyrotrope or a gonado-
trope fate, respectively. binding sites, such as the gonadotrope-specific SF1
promoter, and synergize with GATA2 on genes con-
taining DNA-binding sites for both Pit1 and GATA2 asFunctional Consequences of Pit1
with the promoter for TSHb.and GATA2 Interactions
This model predicts that mutations of Pit1 that impairThe ability of ventral expression of Pit1 to prevent the
its interaction with GATA2 would consequently permitappearance of the gonadotrope phenotype without af-
expression of gonadotrope-specific genes in the pre-fecting GATA2 levels has provided a model in which to
sumptive caudomedial thyrotrope population. The Pit1explore the molecular mechanisms by which Pit1 may
point mutation (W48C) in the Snell genetic dwarf (dw)function as an inhibitor of the GATA2-dependent gonad-
mouse (Li et al., 1990) disrupts the homeodomain struc-otrope program in thyrotropes. Because the described
ture (Jacobson et al., 1997) and inhibits both its interac-interactions between homeodomain and GATA factors
tion with GATA2 (Figure 6B) and DNA binding. As thecould result in either positive (Durocher et al., 1997) or
dw mouse exhibits normal appearance of the Pit11 cellnegative transcriptional consequences, we evaluated
populations but fails to activate TSHb gene expression,the physical interaction between Pit1 and GATA2, ini-
we evaluated whether in this genetic model there mighttially by coimmunoprecipitation of the two proteins from
be an expansion in the gonadotrope cell types. Consis-pituitary-derived cell extracts (Figure 5A), finding Pit1±
tent with the hypothesis that Pit1 suppresses the gonad-GATA2 interaction, as has been previously noted (Gor-
otrope program in thyrotropes, we find that in Snell micedon et al., 1997). We find unexpectedly that Pit1, nor-
the gonadotrope markers LHb and SF1 (Figure 6A) aremally expressed at levels of up to 500,000 copies/cell,
induced in the cells that presumably would have nor-can effectively inhibit GATA2 binding to cognate DNA
mally given rise to caudomedial thyrotropes. This muta-sites, including a putative GATA-binding site within the
tion also provides independent evidence of the abilitySF1 promoter (Figure 5B; Woodson et al., 1997; Viger
of a GATA21, Pit12 cell to assume a gonadotrope fate,et al., 1998), and impair GATA2-dependent transactiva-
complementing the gain-of-function transgenic experi-tion in cotransfection assays (Figure 5C). Conversely,
ments.GATA2 is incapable of inhibition of Pit1 binding to its
cognate site (data not shown). The interaction interface
maps to the homeodomain of Pit1 and to a region of DNA Binding±Independent Functions of Pit1
Because the interaction of GATA2 with Pit1 appears toGATA2 containing the C-terminal DNA-binding zinc fin-
ger and an adjacent cluster of basic residues (Figures 5D involve a surface of the Pit1 homeodomain distinct from
the DNA-binding domain, we wished to further evaluateand 5E). Point mutations on the Pit1 interaction interface
reveal a requirement for residues located in the N-termi- whether the entire program of Pit1 action on cell type
determination is DNA binding dependent or whethernal basic region (R2, K3) and the non-DNA-binding sur-
face of the second helix of the homeodomain (P26, Q29) protein±protein interactions might account for critical
aspects of cell type determination. We therefore gener-(Figure 5F). Further, mutation of residues defined by
NMR structural analysis of GATA1 (Omichinski et al., ated a mutation in the homeodomain of Pit1 (N51A,
(D) Mapping of the Pit1 interaction interface with GATA2. Schematic representations of Pit1 constructs that were expressed as GST-fusion
proteins for interaction assays with 35S-labeled Met GATA2 are shown. Interactions with other classes of homeodomain proteins (e.g., Isl1
and Pbx2) are not detected.
(E) Mapping of the GATA2 interaction interface with Pit1. Interaction assays were performed using a GST fusion of the Pit1 homeodomain
with various fragments and mutants of GATA2.
(F) Fine mapping of the Pit1 homeodomain interaction with GATA2 reveals a requirement for specific residues located in the N terminus of
the homeodomain and near the second helix (reverse lettering).
(G) Alanine substitution of major groove±contacting residues (reverse lettering) in GATA2 only partially weaken interaction with Pit1.
(H) DNA binding of Pit1 and GATA2 on the TSHb promoter. GATA2 binding is inhibited when the Pit1 sites are removed.
(I) Synergistic activation of a multimerized Pit1/GATA2 site from the TSHb promoter (TSHb P/R) by Pit1 and GATA2.
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Figure 6. DNA Binding±Independent Inhibi-
tion of Gonadotrope Determination by Pit1
(A) Snell dwarf (dw) animals display an in-
creased and dorsally expanded gonadotrope
population. In situ hybridization was per-
formed on P0 animals and revealed a dorsal
expansion of LHb and SF1 expression. Simi-
lar results were obtained from analysis of five
pairs of dw/dw and wild-type animals.
(B) Generation of a non-DNA-binding Pit1 mu-
tant (N51A, Q54A) that retains GATA2 interac-
tion. Interaction assays were performed using
a GST fusion of Pit1 and 35S-labeled GATA2
(upper left panel). EMSA and transfections
with the Pit1 DNA-binding mutant (Pit1DBmut)
reveals a loss of DNA binding on a high-affin-
ity Pit1-binding site from the Prl promoter (up-
per right panel) and activation of the autoreg-
ulatory Pit1 promoter/enhancer (P/E) (center
panel). The Pit1DBmut is also capable of inhibi-
tion of GATA2-dependent activation of the
GATA-RE reporter. With mutation of residues
in Pit1 required for GATA2 interaction (ªG2Mº;
K3E, P26S, Q29A as identified in Figure 5F),
the ability to inhibit GATA2-dependent trans-
activation is lost (lower panel).
(C) In vivo expression of Pit1DBmut under control
of aGSU regulatory sequences inhibits go-
nadotrope determination at e18.5. Whereas
TSHb expression is normal, LHb and SF1 lev-
els are dramatically attenuated.
(D) Expression of Pit1DBmut containing the G2M
mutations (Pit1DB/G2M) under control of aGSU
regulatory sequences does not inhibit ap-
pearance of either gonadotropes or thyro-
tropes, in contrast to gonadotrope-specific
effects of the Pit1DBmut. The Pit1DB/G2M trans-
gene expresses at levels comparable to that
of the PitDBmut (data not shown). Similar results
were obtained in all transgenic mice ana-
lyzed.
Q54A) based on its DNA-bound crystal structure (Jacob- critical function of the Pit1 homeodomain includes its
ability to selectively alter components of gene activationson et al., 1997) that prevents DNA binding and DNA
binding±dependent activation but has no effect on inter- programs required for cell type specification through
protein±protein interactions, in this case interacting withaction with GATA2 (Figure 6B) and targeted its expres-
sion under control of aGSU regulatory sequences. As GATA2, inhibiting activation of gonadotrope-specific
genes in thyrotropes.shown in Figure 6C, TSHb continues to be expressed
normally in thyrotropes, indicating that the expression
of the Pit1DBmut does not act to ªsquelchº the binding or Discussion
transcriptional actions of the endogenous Pit1 protein.
However, expression of the aGSU/Pit1DBmut protein effec- GATA2 Mediates the Effects of BMP2
tively blocks the terminal differentiation program of go- in Determination of Pituitary
nadotropes, as indicated by the dramatic loss of LHb Cell Types
and SF1 expression (Figure 6C). Thus, in contrast to The mediation of the effects of transient signaling gradi-
the actions of the aGSU/wild-type Pit1 transgene, the ents on positionally determining the appearance of spe-
aGSU/Pit1DBmut does not convert gonadotropes to thyro- cific cell types in mammalian organogenesis has been
tropes but inhibits their terminal differentiation. hypothesized to be achieved by the induction of overlap-
To more rigorously test whether this effect of the non± ping, spatially distinct patterns of transcription factor
DNA binding form of Pit1 actually reflects its interaction expression. In pituitary development, opposing BMP2
with GATA2, we generated point mutations in the resi- and FGF8 gradients are associated with induction of
dues preceding helix 1 and within helix 2 of the Pit1 distinct combinations of transcription factors and posi-
homeodomain (Pit1G2M) that abolished both the interac- tional determination of the component pituitary cell
tion with GATA2 and the ability to inhibit GATA2-depen- types in a distinct spatial fashion by e12.5. Our data
dent transactivation (Figures 5F and 6B). In vivo expres- suggest that the cell-autonomous programs established
sion of the Pit1-containing mutation of residues required by the transient morphogen gradients are, surprisingly,
ultimately mediated by the actions of two induced tran-for GATA2 interaction in the context of the Pit1DBmut re-
verts the inhibitory effects of Pit1 on gonadotrope deter- scription factors, GATA2 and Pit1, which are both re-
quired and sufficient to establish the remaining tran-mination (Figure 6D), consistent with this effect attrib-
uted to direct inhibition of GATA2 function. Thus, a scriptional programs that dictate terminal differentiation
DNA Binding±Independent Cell Specification by Pit1
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activation of downstream regulators as occurs in Dro-
sophila eye development (Halder et al., 1995), in the
actions of bHLH factors in myogenesis (Weintraub,
1993; Firulli and Olson, 1997), and by a homeodomain
protein in the emergence of specific motor neurons in
the neural tube (Tanabe et al., 1998). Thus, GATA2, which
earlier in development is required for the expansion of
hematopoietic precursors (Tsai et al., 1994) and the de-
velopment of the placental trophoblast (Ma et al., 1997)
and urogenital system (Zhou et al., 1998), also plays a
critical role in pituitary cell type determination.
DNA Binding±Independent Roles of Pit1
in Cell Type Determination
Pit1 is prototypic of developmentally important tran-
scription factors that are expressed at unusually high
levels, in this case up to 500,000 copies of Pit1/cell,Figure 7. Model for Pituitary Cell Type Determination by Pit1 and
GATA2 making it of particular interest to determine whether
The reciprocal interactions of Pit1 and GATA2 and the DNA binding± actions in addition to its role as a DNA-binding transcrip-
independent actions of Pit1 serve as the cell-autonomous ªmole- tion factor are critical for its function. In this paper, we
cular memoryº that mediates the generation of four pituitary cell have provided evidence that Pit1 can modify the actions
phenotypes in response to transient signaling gradients. The com-
of a second factor, GATA2, based on protein±proteinplement of Pit1 and GATA2 cis-active elements dictates gonado-
interactions that contribute specifically to cell type de-trope- and thyrotrope-specific gene expression. This model pro-
termination. We demonstrate that the interaction of thevides a molecular mechanism by which the specific interaction of
two factors can simultaneously generate an ªactivatorº of a cohort Pit1 homeodomain with the C-terminal zinc finger of
of genes expressed in a specific type and a ªrepressorº of a distinct GATA2 inhibits its binding to a subset of cognate DNA
second set of genes that are excluded. sites, unless there is an adjacent Pit1 DNA-binding site.
This appears in vivo to account for the ability of Pit1 to
inhibit gonadotrope-specific aspects of the ventral cellof four anterior pituitary cell types. In part, this cell type
specification program is achieved by reciprocal, mecha- type differentiation program.
The residues of the Pit1 homeodomain required fornistically distinct inhibitory and synergistic interactions
between these two induced factors (Figure 7). interaction with GATA2 suggest a bipartite interaction
surface, including the basic cluster of amino acids pre-Our data suggest that the ventral→dorsal BMP2 gradi-
ent induces GATA2 in a corresponding gradient in pre- ceding the first helix of the homeodomain and the
N-terminal portion of the second helix, consistent withsumptive gonadotropes and thyrotropes and that the
high levels of GATA2 in the most ventral aspect of the the ability of Pit1 to bind cognate DNA sites even in the
presence of excess GATA2. In contrast, the inhibitiongland directly or indirectly restricts Pit1 gene expression
out of the presumptive gonadotropes, creating the criti- of GATA2 binding in the presence of Pit1 reflects an
interaction interface of GATA2 that is its DNA-bindingcal delineation of the gonadotrope and Pit1 cell lineages.
In the absence of Pit1, GATA2 expression appears suffi- surface. However, a subset of Pit1- and GATA2-depen-
dent genes, such as TSHb, which have adjacent bindingcient to induce the entire set of transcription factors that
are typical of the gonadotrope cell type, including the sites for both proteins, escape this inhibiting effect. This
is apparently due to allosteric effects imparted by thetranscription factors SF1, P-Frk, and Isl1. Conversely,
the absence of GATA2 dorsally is critical for differentia- binding of Pit1 to DNA sites that permit a Pit1±GATA2
conformation that no longer inhibits specific DNA bind-tion of Pit11 cells to somatotrope/lactotrope fates, as
the targeting of GATA2 more dorsally inhibits initial Pit1 ing by GATA2. Thus, Pit1±GATA2 protein±protein inter-
actions can lead to gene-specific actions that haveexpression and converts these cells to gonadotropes.
Similarly, targeting overexpression of BMP2/4 also in- come to assume cell-specific roles.
We therefore suggest that a critical component of thehibits Pit1 expression, although the cell types fail to
terminally differentiate (Treier et al., 1998). We hypothesize cell type determination program is achieved through the
inhibition by Pit1 of GATA2-dependent gonadotrope-that the level of GATA2 expression in the thyrotropes,
however, is below the threshold required to inhibit acti- specific genes while simultaneously permitting GATA2-
dependent gene activation critical for establishing thevation of the Pit1 gene early enhancer, permitting the
emergence of a Pit11, GATA21 cell, dictating a pattern thyrotrope phenotype. Two types of in vivo data support
a DNA binding±independent role of Pit1. The first is thatof gene expression that defines a thyrotrope. This inter-
pretation is supported by the ability to convert a gonado- targeted expression of a non-DNA-binding form of Pit1,
still capable of interaction with GATA2, inhibits thetrope to a thyrotrope cell fate by ventral extension of
Pit1 expression to the Pit12, GATA21 field. gonadotrope-specific terminal differentiation program,
while point mutations that abolish the Pit1±GATA2 inter-Thus, between e13.5±e17.5, Pit11, GATA22 cells will
terminally differentiate to somatotropes/lactotropes; action revert this inhibitory effect. Second, this hypothe-
sis receives genetic confirmation based on develop-Pit1, GATA21 cells to thyrotropes; and GATA21, Pit2
cells to gonadotropes. These results conceptually ex- mental events in the Snell dw dwarf mouse in which
the W48C mutation in Pit1 disrupts the homeodomaintend observations suggesting that a single transcription
factor can induce cell determination events by triggering structure and impairs interaction with GATA2 and in
Cell
596
of expression and identical phenotypes. All other transgenic animalswhich the presumptive thyrotropes now express the
were obtained from embryonic founders. Tissues were fixed in eitherGATA2-dependent gonadotrope gene activation pro-
10% formalin for analysis by in situ hybridization or in 10% formalde-gram. This provides direct evidence that Pit1-dependent
hyde, 60% EtOH for 2±3 hr for immunohistochemistry.
inhibition of GATA2-dependent activation of gonado-
trope-specific genes is a critical component by which In Situ Hybridization and Immunohistochemistry
Pit1 controls the thyrotrope-specific program. Thus, In situ hybridization was performed as previously described (Sim-
DNA binding±independent inhibitory protein±protein in- mons et al., 1990) on 20 mm cryosections using 35S-labeled antisense
RNA probes. For immunohistochemistry, embryos or adult pituitar-teractions by the highly abundant Pit1 transcription fac-
ies were dehydrated in ethanol, embedded in paraffin, sectioned attor, in addition to its DNA-dependent transcriptional ac-
8±10 mm, and mounted on Superfrost Plus slides (Fischer). Sectionstivation roles, is a critical component of the cell type
were incubated with primary antibody at a 1:200 dilution in PBS,
specification and suggests similar functions for other 0.3% Triton X-100, 5% normal goat serum overnight at 48C. After
POU domain or other classes of homeodomain factors. washing three times in PBS, slides were incubated with HRP-cou-
The ability to overcome the inhibitory effects of Pit1 pled secondary antibodies (Chemicon) at a 1:200 dilution for 3 hr
at room temperature. Staining was visualized using a DAB metalon GATA2 on promoters not containing adjacent Pit1
conjugate (Pierce). Sections were counterstained with methyl greenand GATA2 DNA-binding sites is analogous to events
and mounted on Permount (Fischer). For analysis of adult pituitariesin the well-documented transrepression of AP1 by glu-
by immunofluorescence, pituitaries were incubated with primary
cocorticoid receptor (Jonat et al., 1990; Kamei et al., antibody overnight at 48C, followed by incubation with TRITC- or
1996). Indeed, the biological importance of the non-DNA FITC-coupled secondary antibodies (Chemicon) at a 1:200 dilution.
binding component of glucocorticoid receptor actions Sections were then mounted using the Slow Fade antifade kit (Mo-
lecular Probes).has been shown in vivo by mutation of the glucocorticoid
Primary antibodies used were obtained as follows; aGH, aPrl,receptor DNA-binding domain (Reichardt et al., 1998).
aTSHb, DAKO, Carpinteria, CA; a-aGSU, aLHb, National HormoneThe data presented here show that this type of transre-
and Pituitary Program, NIDDK, Rockville, MD; aHA, Babco; and
pression has been functionally adapted in cell type de-
aGATA2, provided by S. Orkin, Harvard, Cambridge, MA.
termination events. Thus, while the role of protein±pro-
tein interactions in the function of transcription factors Transfections and DNA Binding Assays
such as Hox and Pbx factors (reviewed by Mann and Cotransfection experiments were performed as previously de-
scribed (Rhodes et al., 1993) in HeLa and COS7 cells, using 1 mgChan, 1996), Bob1/OCA-B/Obf1 for Oct1 (Luo et al.,
of luciferase reporter, 50±500 ng pCMX expression plasmids, and1992; Gstaiger et al., 1995; Strubin et al., 1995), bHLH
500 ng of pRSVbGal as an internal control for differences in transfec-and MADS box factors (Molkentin et al., 1995), and FOG
tion efficiencies. The GATA-RE luciferase reporter was generated by
for GATA1 (Tsang et al., 1997) has been established, multimerization of annealed oligonucleotides containing two GATA-
our study reveals that a critical component of the cell binding sites (59-CACTTGATAACACAAAGTGATAACTCT-39) and
type±specific actions of developmentally regulated DNA- cloned upstream of a minimal promoter (P36) derived from the pro-
lactin gene (Lin et al., 1994) or the thymidine kinase (TK) promoter.binding transcription factors is to modulate, by DNA-inde-
The TSHb reporter was generated by PCR amplification of the mu-pendent interactions, the function of other DNA-depen-
rine promoter region (nt 2145 to 262) and similarly multimerized.dent transcription factors on a subset of their target
The GATA site in the SF1 gene was derived from nt 2189 to 2157genes.
of the murine promoter (59-GGGCCCCCATAAAGATAGGGATATTTT
We suspect that these DNA binding±dependent and TTTTTC-39). DNA binding assays were performed using g-32P-
±independent actions of Pit1 will prove to be prototypic labeled ATP double-stranded and gel-purified oligonucleotides as
previously described (Rhodes et al., 1993). Other reporter constructsof the actions of many highly expressed transcriptional
and DNA sites used in this study have been described previouslyregulatory factors in the development of other mamma-
(Rhodes et al., 1993)lian organs.
Immunoprecipitations and Protein Interaction AssaysExperimental Procedures
For coimmunoprecipitation studies, 100 mm plates of pituitary GC
cells were transfected with 5 mg of a CMV-HA-GATA2 expressionPlasmid Constructions for Transgenic Animals
vector using the Lipofectamine Plus reagent (GIBCO±BRL). After 48Plasmid DNA for generation of transgenic mice were constructed
hr, cells were harvested and lysed in 600 ml binding buffer containingby insertion of cDNAs into a vector cassette containing a 59-b-
20 mM Tris (pH 7.8), 150 mM NaCl, 0.1% NP-40, 10% glycerol, 0.5globin intron and a 39-polyadenylation signal from the human growth
mM EDTA, and 13 Complete Protease Inhibitor Cocktail (Boehringerhormone gene as previously described (Treier et al., 1998). The
Mannheim). Lysates were incubated with 3 ml of rabbit polyclonalmurine GATA2 cDNA was obtained by PCR amplification of e14.5
a-Pit1 antiserum for 8 hr at 48C, precipitated with protein A/G pluspituitary cDNA and cloned in frame with the HA epitope at the N
agarose, and washed four times in binding buffer. Complexes wereterminus. The dnGATA2 transgene was constructed by fusion of the
resolved by 8% SDS-PAGE and transferred to nitrocellulose mem-Engrailed repressor domain (aa 2±229) to the DNA-binding region
branes. GATA2 was detected using an a-HA monoclonal antibodyand C terminus of GATA2 (aa 260±481). For the Pit1 transgenic
(Babco) at a 1:3000 dilution, followed by anti-mouse HRP-coupledconstructs, the full-length 1.6 kb rat cDNA was used, and point
secondary antibodies (1:3000), and developed by ECL (Amersham).mutations were generated using the Quick Change Mutagenesis kit
Protein preparation and interaction studies were performed as(Stratagene).
described (Kamei et al., 1996). Fragments encoding the full-length
Pit1 (aa 1±291), the homeodomain of Pit1 (aa 206±291), and theGeneration of Transgenic Animals
zinc finger region plus the C terminus of GATA2 (aa 291±481) werePlasmid DNA for transgenic constructs was prepared by standard
generated by PCR amplification and cloned in frame into the GSTprocedures, purified by gel electrophoresis, dialyzed against 10 mM
expression plasmid pGEX2TK (Pharmacia). Fragments of Pit1 andTris (pH 7.5), 1 mM EDTA, and microinjected as described (Crenshaw
GATA2 for mapping interaction domains were also generated byet al., 1989). Founder animals were analyzed for integration by PCR
PCR and cloned into the plasmid pCDNA3-KATG for in vitro tran-and Southern blot analysis. All transgenic animals used in this study
scription and translation from rabbit reticulocyte lysates usingwere determined to have integrated approximately three to ten cop-
35S-labeled methionine (Promega). Point mutations in Pit1 andies of the transgene. Data for the Pit1/GATA2 transgene were ob-
tained from two independent transgenic lines, showing similar levels GATA2 were generated using the Quick Change Mutagenesis kit
DNA Binding±Independent Cell Specification by Pit1
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(Stratagene) and were confirmed by DNA sequencing. For the inter- pouch morphogenesis in the chick embryo. J. Exp. Zool. 207,
351±366.action assays, 0.1±0.5 mg of GST proteins were combined with
35S-labeled proteins in a binding/washing buffer containing 150 mM Jacobson, E.M., Li, P., Leon-del-Rio, A., Rosenfeld, M.G., and Ag-
NaCl, 20 mM Tris (pH 7.8), 10% glycerol, 0.02% NP-40, and 0.5 mM garwal, A.K. (1997). Structure of Pit-1 POU domain bound to DNA
DTT. GST-coupled and 35S-labeled proteins were bound for 1 hr at as a dimer: unexpected arrangement and flexibility. Genes Dev. 11,
48C, washed four times, and interactions visualized after SDS-PAGE 198±212.
and autoradiography. Japon, M.A., Rubinstein, M., and Low, M.J. (1994). In situ hybridiza-
tion analysis of anterior pituitary hormone gene expression during
fetal mouse development. J. Histochem. Cytochem. 42, 117±125.Acknowledgments
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